Michael M. Tarnow

Insider Reports History

Entity
Individual
Signature
/s/ Cassandra Robinson, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael M. Tarnow:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xenon Pharmaceuticals Inc. Director Common Shares 77.9K $768K $9.85 May 18, 2021 Direct
Xenon Pharmaceuticals Inc. Director Stock Option (Right to Buy) 0 May 18, 2021 Direct

Insider Reports Filed by Michael M. Tarnow

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XENE Xenon Pharmaceuticals Inc. May 18, 2021 6 $30.6K 4 May 20, 2021 Director